Rxwire
In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AbbVie 3 AstraZeneca 3 Daiichi Sankyo 2
Trials & R&D · first seen yesterday, updated 12h ago

J&J says analysis demonstrates potential of Tecvayli-Darzalex combo for multiple myeloma

2 outlets Johnson & Johnson

Coverage 2 articles · 2 outlets

  1. Seeking Alpha Healthcare
    J&J says analysis demonstrates potential of Tecvayli-Darzalex combo for multiple myeloma
  2. BioPharm International